The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorDeutsches Herzzentrum Muenchen
About this trial
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age above 18 years and consentable
Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
Written informed consent
Disqualifiers
Patient's inability to fully cooperate with the protocol
Trial population
All-comers patient population treated with transcatheter mitral or tricuspid valve therapy
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
edge-to-edge valve repair
Deviceedge-to-edge valve repair
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Long-term mortality
Long-term mortality
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov